Juerg Reichen

3.0k total citations
32 papers, 2.0k citations indexed

About

Juerg Reichen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Juerg Reichen has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Juerg Reichen's work include Liver Disease Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease and Transplantation (5 papers). Juerg Reichen is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease and Transplantation (5 papers). Juerg Reichen collaborates with scholars based in Switzerland, United States and Netherlands. Juerg Reichen's co-authors include Michael P. Manns, Harry L.A. Janssen, Bettina E. Hansen, Solko W. Schalm, Heiner Wedemeyer, Stefan Zeuzem, Arthur Zimmermann, Bart J. Veldt, Paul D. Berk and E. Jenny Heathcote and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Hepatology.

In The Last Decade

Juerg Reichen

31 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juerg Reichen Switzerland	19	946	906	539	477	255	32	2.0k
Richard Kirsch South Africa	9	754 0.8×	196 0.2×	176 0.3×	138 0.3×	391 1.5×	14	1.5k
F Paronetto United States	21	609 0.6×	565 0.6×	252 0.5×	248 0.5×	283 1.1×	71	1.8k
N C Nayak India	24	1.1k 1.2×	1.1k 1.2×	337 0.6×	125 0.3×	195 0.8×	84	2.1k
Myoung Kuk Jang South Korea	23	1.1k 1.1×	1.0k 1.2×	398 0.7×	113 0.2×	312 1.2×	75	2.0k
Vincent Vercruysse Belgium	16	521 0.6×	221 0.2×	95 0.2×	263 0.6×	133 0.5×	28	1.1k
Norio Horiike Japan	35	2.2k 2.3×	2.2k 2.4×	326 0.6×	135 0.3×	269 1.1×	166	3.8k
Hans‐Peter Dienes Germany	31	2.2k 2.3×	2.3k 2.6×	753 1.4×	149 0.3×	795 3.1×	57	4.0k
Yukihiro Shimizu Japan	28	634 0.7×	514 0.6×	286 0.5×	113 0.2×	412 1.6×	66	2.3k
Amon Asgharpour United States	16	719 0.8×	372 0.4×	318 0.6×	82 0.2×	315 1.2×	39	1.4k
Elvino José Guardão Barros Brazil	21	114 0.1×	248 0.3×	436 0.8×	121 0.3×	769 3.0×	48	1.9k

Countries citing papers authored by Juerg Reichen

Since Specialization

Citations

This map shows the geographic impact of Juerg Reichen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juerg Reichen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juerg Reichen more than expected).

Fields of papers citing papers by Juerg Reichen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juerg Reichen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juerg Reichen. The network helps show where Juerg Reichen may publish in the future.

Co-authorship network of co-authors of Juerg Reichen

This figure shows the co-authorship network connecting the top 25 collaborators of Juerg Reichen. A scholar is included among the top collaborators of Juerg Reichen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juerg Reichen. Juerg Reichen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veldt, Bart J., Wendong Chen, Jenny Heathcote, et al.. (2008). Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 47(6). 1856–1862. 220 indexed citations

Bruegger, Lukas E., Peter Studer, Stefan Schmid, et al.. (2007). Indocyanine Green Plasma Disappearance Rate During the Anhepatic Phase of Orthotopic Liver Transplantation. Journal of Gastrointestinal Surgery. 12(1). 67–72. 16 indexed citations

Schoepfer, Alain, Karin Fattinger, Urs Marbet, et al.. (2007). Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products. Journal of Hepatology. 47(4). 521–526. 121 indexed citations

Veldt, Bart J., E. Jenny Heathcote, Heiner Wedemeyer, et al.. (2007). Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis. Annals of Internal Medicine. 147(10). 677–684. 438 indexed citations

Neef, Markus, et al.. (2006). Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Journal of Hepatology. 45(6). 786–796. 117 indexed citations

Shaw, Sidney, et al.. (2006). Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin.. PubMed. 231(6). 1101–5. 33 indexed citations

Neef, Markus, M Ledermann, Vreni Schneider, et al.. (2005). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of Hepatology. 44(1). 167–175. 73 indexed citations

Stumm, Michael, et al.. (2002). Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver International. 22(6). 441–450. 26 indexed citations

Dufour, Jean‐François, Matthias Zimmermann, & Juerg Reichen. (2002). Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare. Journal of Hepatology. 36. 152–153. 2 indexed citations

10.

Zimmermann, Arthur, et al.. (2001). The diagnostic value of liver biopsy. BMC Gastroenterology. 1(1). 12–12. 40 indexed citations

11.

Reichen, Juerg. (2001). THE BRIDGE – July 2001. Journal of Hepatology. 35(1). 1–1. 1 indexed citations

12.

Reichen, Juerg. (2001). THE BRIDGE – March 2001. Journal of Hepatology. 34(3). 359–359. 1 indexed citations

13.

Everson, Gregory T., Ann Scherzinger, Juerg Reichen, et al.. (1988). Polycystic liver disease: Quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts. Hepatology. 8(6). 1627–1634. 74 indexed citations

14.

Kloppel, Thomas Μ., William R. Brown, & Juerg Reichen. (1986). Mechanisms of secretion of proteins into bile: Studies in the perfused rat liver. Hepatology. 6(4). 587–594. 36 indexed citations

15.

Kloppel, Thomas Μ., William R. Brown, & Juerg Reichen. (1986). Effects of monensin on vesicular transport pathways in the perfused rat liver. Journal of Cellular Biochemistry. 32(3). 235–245. 18 indexed citations

16.

Fritzberg, Alan R. & Juerg Reichen. (1985). Extraction efficiency and biliary excretion of hepatobiliary imaging agents in the rat perfused liver. Journal of Pharmacy and Pharmacology. 37(12). 919–922. 3 indexed citations

17.

Reichen, Juerg, et al.. (1984). Aphthous Ulceration in Diversion Colitis. Gastroenterology. 87(5). 1171–1173. 32 indexed citations

18.

Berry, William R. & Juerg Reichen. (1983). Bile Acid Metabolism: Its Relation to Clinical Disease. Seminars in Liver Disease. 3(4). 330–340. 18 indexed citations

19.

Reichen, Juerg, Bennett L. Blitzer, & Paul D. Berk. (1981). Binding of unconjugated and conjugated sulfobromophthalein to rat liver plasma membrane fractions in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 640(1). 298–312. 34 indexed citations

20.

Reichen, Juerg, M. Berman, & Paul D. Berk. (1981). The role of microfilaments and of microtubules in taurocholate uptake by isolated rat liver cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 643(1). 126–133. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact